Loading organizations...
Key people at Eckuity Capital.
Eckuity Capital is a healthcare-focused growth equity firm investing in established middle-market companies. It targets businesses with clinical relevance, scalable models, and durable market positions across MedTech, HealthTech, and Biotech Services. The firm partners with management teams, providing strategic support in commercialization and market expansion to foster disciplined growth and value.
Youssef Sebban founded Eckuity Capital and serves as Managing Partner. Dr. Victoria Manax Rutson, MD, is a Founding General Partner, with Karim Maasarani also a General Partner. Their deep expertise in healthcare investing and clinical innovation underpins the firm's approach, merging scientific innovation with commercial scalability.
Established middle-market healthcare companies seek Eckuity Capital for growth capital and strategic guidance. The firm's vision is to drive improved patient outcomes and cost reduction in healthcare by supporting impactful, efficient solutions. Eckuity Capital aims to build capital-efficient, scalable businesses with diverse paths to liquidity, while promoting sustainable and purpose-driven practices.
Key people at Eckuity Capital.
Eckuity Capital has 3 tracked investments across 3 companies. The latest tracked deal is $56.5M Other Equity in Avive Solutions in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 19, 2024 | Avive Solutions | $56.5M Other Equity | Catalyst Health Ventures, Laerdal, Ryan Drant | — |
| Apr 1, 2024 | Endeavor BioMedicines | $130.0M Series C | Ayurmaya, Karan Takhar | Atlas Venture, Hatteras Venture Partners, Omega Funds, RA Capital, Roche Venture Fund, Abrdn, Ally Bridge Group, Avidity Partners, Fidelity Management & Research Company, Invus, Longitude Capital, Perceptive Advisors, Piper Heartland Healthcare Capital, Silver Arch BIO, SymBiosis, T. Rowe Price Associates, Velosity Capital, Woodline Partners |
| Sep 13, 2023 | AWAK Technologies | $20.0M Series B | Irene GUO, Mhamed Mengad, CFA | Abel ANG |